IndustriesServices-Commercial Physical & Biological Research
Services-Commercial Physical & Biological Research
Open in the ScreenerCompanies
12Median grade
4.72Highest
MEDP 7.82Lowest
ISPC 3.11A grade ranks a company against its own industry, from its filings. It is not a view on the share price. 12 of 5,495 companies on file are in this industry.
| Company, by grade | Grade | ◀ Past | ● Present | ▶ Future | Arc | Filed |
|---|---|---|---|---|---|---|
| 1MEDPMedpace Holdings, Inc. | 7.82 | 8.2 | 7.8 | 7.2 | Falling | 9 of 9 |
| 2INCYIncyte Corp. | 7.53 | 7.7 | 7.1 | 7.8 | Rising | 9 of 9 |
| 3IQVIQVIA Holdings Inc. | 6.75 | 7.5 | 7.1 | 5.2 | Falling | 9 of 9 |
| 4ICLRICON plc | 5.67 | 6.2 | 6.0 | 4.4 | Falling | 8 of 9 |
| 5NRCNRC Health | 5.34 | 5.9 | 5.3 | 4.6 | Falling | 9 of 9 |
| 6CRLCharles River Laboratories International, Inc. | 5.22 | 6.0 | 5.1 | 4.1 | Falling | 9 of 9 |
| 7MXCTMaxCyte, Inc. | 4.23 | 4.0 | 4.7 | 4.0 | Level | 8 of 9 |
| 8OABIOmniAb, Inc. | 4.01 | 2.4 | 5.9 | 3.4 | Rising | 7 of 9 |
| 9BIAFbioAffinity Technologies, Inc. | 3.95 | 3.3 | 3.8 | 4.5 | Rising | 7 of 9 |
| 10ABSIAbsci Corporation | 3.91 | 3.8 | 4.1 | 3.8 | Level | 8 of 9 |
| 11ONMDOneMedNet Corp | 3.45 | 1.8 | 1.9 | 5.9 | Rising | 8 of 9 |
| 12ISPCiSpecimen Inc. | 3.11 | 1.4 | 2.5 | 4.7 | Rising | 6 of 9 |
New in the recordsince Oct 30, 2026
- Nov 12ABSIFiled its quarterly report 10-Q
- Nov 12ABSIReleased results 8-K
- Nov 10MXCTFiled its quarterly report 10-Q
- Nov 10MXCTReleased results 8-K
- Nov 9ISPCSigned a major agreement 8-K
- Nov 9ONMDReleased results 8-K
- Nov 6BIAFReleased results 8-K
- Nov 6BIAFFiled its quarterly report 10-Q
- Nov 6ONMDReleased results 8-K
- Nov 5ISPCCompleted an acquisition or a disposal 8-K
- Nov 4CRLFiled its quarterly report 10-Q
- Nov 4CRLReleased results 8-K
Filings read from SEC EDGAR, as of Nov 13, 2026.
Next deadlinesfrom the SEC's rules
- Nov 14ISPC10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
- Nov 14ONMD10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
- Feb 25CRL10-K due under the SEC's rules, the annual report for the period ended 2026-12-27
- Mar 1INCY10-K due under the SEC's rules, the annual report for the period ended 2026-12-31
- Mar 1IQV10-K due under the SEC's rules, the annual report for the period ended 2026-12-31
- Mar 1MEDP10-K due under the SEC's rules, the annual report for the period ended 2026-12-31
A deadline is the rule's date for the filer's category, never a prediction.